Exploring advanced imaging techniques for studying biological structures
Official title: Pacific Northwest Center for Cryo-EM
Funded at Oregon Health & Science University · NIH-11161449 · Data updated 2026-11-12
This study is all about using a special imaging technology called cryo-electron microscopy to help scientists see tiny biological molecules more clearly, making it easier for them to understand how they work and develop new treatments, and it's designed for researchers who want to learn and improve their skills in this area.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | August 10, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $6,534,773 |
| NIH project number | 5R24GM154185-02 |
| Project ID | NIH-11161449 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include researchers and scientists in the fields of molecular biology, biochemistry, and related disciplines who require access to advanced imaging technologies.
✕Less likely to help
Patients who are not involved in research or do not work in scientific fields may not receive direct benefits from this research.
What this research studies
This research focuses on cryo-electron microscopy (cryo-EM), a cutting-edge imaging technology that allows scientists to visualize biological molecules in unprecedented detail. The Pacific Northwest Center for Cryo-EM aims to enhance access to this technology and provide training for researchers, enabling them to study complex biological systems and interactions. By integrating advancements in machine learning and artificial intelligence, the project seeks to improve the efficiency and effectiveness of cryo-EM workflows. This initiative will support discoveries in various fields, including basic science and drug development.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding complex biological processes, potentially improving drug development and treatment strategies.
How similar studies have gone: Previous research in cryo-EM has shown significant success in advancing our understanding of molecular structures, indicating that this approach is both effective and promising.
Where this research is happening
-
Oregon Health & Science University
Portland, United States Active
Researchers
- Principal investigator: Reichow, Stephen Loen — Oregon Health & Science University
- Study coordinator: Reichow, Stephen Loen
Related research
Other NIH-funded projects on the same topics.
-
Understanding how a protein affects nerve cell movement in Alzheimer's disease
This study is looking at how a protein called APP affects the growth and movement of nerve cells, which is important for understanding Alzheimer's disease, and it aims to find out how problems with this protein might lead to nerve cell damage.
-
Understanding how the bone marrow environment drives AML resistance
A large NIH-funded project at Oregon Health & Science University is studying how the body’s own cell surroundings help acute myeloid leukemia become resistant to treatment, with potential paths to better therapies for patients.
-
Improving Safety at Work with a Low-Resource mHealth Program in Malaysia (and beyond)
A low-cost mobile health program to improve safety culture in Malaysian workplaces, with plans to adapt the approach for U.S. workers in high-risk industries.
-
Oregon Healthy Workplace Initiative for Better Health
A multi-site effort aims to improve the health and safety of workers by coordinating research, tools, and interventions across workplaces.
-
Understanding how AML cells become resistant to therapy over time
This project looks at why acute myeloid leukemia stops responding to treatment and how to design better drug combinations to prevent relapse.
-
Mechanisms and Countermeasures for Ultra-Potent Synthetic Opioid Overdose
A small, focused NIH grant aims to understand why ultra-potent synthetic opioids cause severe overdose and to explore potential countermeasures to keep people safe.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.